Exploring New Horizons for Prostate Cancer Patients
Prostate Cancer Research Study
Helios Clinical Research is conducting a clinical study on metastatic castration-sensitive prostate cancer. The purpose of this study is to evaluate the efficacy and safety of an investigational medication in combination with Physician’s Choice New Hormonal Agents. Your involvement could help us make a significant breakthrough in prostate cancer treatment. Compensation up to $2,200.00 for study-related time and travel.